Brief: Ac Immune To Receive Research Grant From Goradia Family For Development Of Aci-7104 In Parkinson’S Disease
11/06/2026 12:02
BRIEF-Ac Immune To Receive Research Grant From Goradia Family For Development Of Aci-7104 In Parkinson’S Disease June 11 (Reuters) - AC Immune SA ACIU.O:
AC IMMUNE TO RECEIVE RESEARCH GRANT FROM GORADIA FAMILY FOR DEVELOPMENT OF ACI-7104 IN PARKINSON’S DISEASE
AC IMMUNE - PLANNED EXTENSION TO ASSESS LONG-TERM SAFETY AND EFFICACY OF ACI-7104 FOR 2 YEARS
AC IMMUNE - FINAL DATA FROM PART 1 OF VACSYN TRIAL EXPECTED IN H2 2026
Source text: ID:nGNX2sf5Kg
Further company coverage: ACIU.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AC Immune AG
See all newsAC Immune rises after Parkinson's drug shows promise in mid-stage trial
Brief: Ac Immune Reports Positive Safety & Immunogenicity At Week-100 In Part 1 Of Vacsyn Phase 2 Trial Of Aci-7104
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
U.S. STOCKS ON THE MOVE-Duke Energy, Sea, Cardinal Health